• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症伴双膦酸盐相关骨坏死患者行颌骨切除术的长期疗效。

Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis.

机构信息

Section of Oral and Maxillofacial Surgery, Department of Surgery, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

出版信息

Oral Oncol. 2011 May;47(5):420-4. doi: 10.1016/j.oraloncology.2011.02.024. Epub 2011 Mar 24.

DOI:10.1016/j.oraloncology.2011.02.024
PMID:21439892
Abstract

Surgical treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) is controversial. Current recommendations contraindicate aggressive surgery because its results are unpredictable and may trigger disease progression. In this prospective study, we assessed the effectiveness of surgical resection of the jaws in cancer patients with BRONJ. Between June 2004 and July 2009, 30 cancer patients with refractory BRONJ underwent surgical resection of the jaws at our Units. They were followed-up weekly for the first month, at 3-month intervals up to 1 year, and at 6-month intervals up to 2 years. Panoramic radiographs and CT-scan were obtained at 3, 6, 12, 18 and 24 months. Primary outcomes were the 24-month recurrence rate of BRONJ and the 24-month mortality rate. Secondary outcomes were post-operative complications, duration of hospital stay after surgery, time to return to oral diet, and degree of oral pain. The 30 patients had a median age of 66 years and were mostly females (80%). Twenty-eight underwent a single resection and two had both jaws resected, for a total of 32 resected jaws. The cumulative recurrence rate of BRONJ in resected jaws 3.1% and 9.4% at 3 and 6 months, respectively. All the jaws with recurrent BRONJ had osteomyelitis at the margins of bone resection. The cumulative incidence of death was 3%, 12% and 16% at 12, 18 and 24 months. Surgical resection of BRONJ was highly effective, with few post-operative complications and were not associated with long-term mortality.

摘要

手术治疗双膦酸盐相关性颌骨骨坏死(BRONJ)存在争议。目前的建议禁忌积极手术,因为其结果不可预测,并且可能引发疾病进展。在这项前瞻性研究中,我们评估了手术切除颌骨在癌症伴 BRONJ 患者中的有效性。2004 年 6 月至 2009 年 7 月期间,我们单位对 30 例难治性 BRONJ 癌症患者进行了颌骨手术切除。术后 1 个月每周随访 1 次,第 1 年每 3 个月随访 1 次,第 2 年每 6 个月随访 1 次。在第 3、6、12、18 和 24 个月时获取全景 X 线和 CT 扫描。主要结局是 BRONJ 的 24 个月复发率和 24 个月死亡率。次要结局是术后并发症、手术后住院时间、恢复口腔饮食的时间和口腔疼痛程度。30 例患者的中位年龄为 66 岁,大多数为女性(80%)。28 例患者接受了单次切除,2 例患者接受了双侧颌骨切除,共切除了 32 个颌骨。切除颌骨的 BRONJ 累积复发率分别为 3 个月时 3.1%和 6 个月时 9.4%。所有复发 BRONJ 的颌骨均有骨切除边缘骨髓炎。12、18 和 24 个月时的死亡率分别为 3%、12%和 16%。BRONJ 的手术切除非常有效,术后并发症少,与长期死亡率无关。

相似文献

1
Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis.癌症伴双膦酸盐相关骨坏死患者行颌骨切除术的长期疗效。
Oral Oncol. 2011 May;47(5):420-4. doi: 10.1016/j.oraloncology.2011.02.024. Epub 2011 Mar 24.
2
The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.手术切除在双膦酸盐相关颌骨骨坏死治疗中的作用。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006.
3
Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.双膦酸盐相关颌骨骨坏死的荧光引导下骨切除术:一项前瞻性初步研究的首个临床结果
J Oral Maxillofac Surg. 2011 Jan;69(1):84-91. doi: 10.1016/j.joms.2010.07.014. Epub 2010 Oct 25.
4
Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.双膦酸盐相关颌骨骨坏死的外科治疗结果:33例手术病例回顾
J Oral Maxillofac Surg. 2009 May;67(5):943-50. doi: 10.1016/j.joms.2008.12.057.
5
Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma.双膦酸盐相关颌骨坏死——部分骨切除联合自体富血小板血浆治疗的首例病例系列报告
J Oral Maxillofac Surg. 2011 Sep;69(9):2465-72. doi: 10.1016/j.joms.2011.02.078. Epub 2011 Jul 16.
6
Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.日本全国范围内双膦酸盐相关颌骨坏死的调查。
J Oral Maxillofac Surg. 2011 Nov;69(11):e364-71. doi: 10.1016/j.joms.2011.03.051. Epub 2011 Jul 23.
7
Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.双膦酸盐相关颌骨坏死:ErCrYSGG激光手术治疗。病例报告。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Dec;110(6):e1-6. doi: 10.1016/j.tripleo.2010.08.013.
8
Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients.颌骨骨坏死与双膦酸盐相关:如何管理癌症患者。
Oral Oncol. 2010 Jun;46(6):468-70. doi: 10.1016/j.oraloncology.2010.03.016. Epub 2010 May 10.
9
Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap.双膦酸盐相关性颌骨坏死——微血管髂骨瓣中的表现。
Oral Oncol. 2011 May;47(5):425-9. doi: 10.1016/j.oraloncology.2011.03.022. Epub 2011 Apr 7.
10
The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.手术治疗在颌骨静脉注射双膦酸盐相关骨坏死管理中的作用。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Feb;111(2):153-63. doi: 10.1016/j.tripleo.2010.04.015. Epub 2010 Jul 31.

引用本文的文献

1
Pilot study of a novel resection extent determination method using bone single-photon emission CT-standardized uptake value in medication-related osteonecrosis of the jaw.一项关于使用骨单光子发射计算机断层扫描标准化摄取值来确定颌骨药物相关性骨坏死新切除范围测定方法的初步研究。
Dentomaxillofac Radiol. 2025 Sep 1;54(6):495-501. doi: 10.1093/dmfr/twaf032.
2
Case Report: Virtual surgery and 3D printing in a medication-related osteonecrosis of the jaws (MRONJ) pathological mandibular fracture.病例报告:虚拟手术与3D打印在药物相关性颌骨坏死(MRONJ)病理性下颌骨骨折中的应用
Front Oral Health. 2025 Mar 28;6:1520195. doi: 10.3389/froh.2025.1520195. eCollection 2025.
3
Determination of adequate bony resection margins in inflammatory jaw pathologies using SPECT-CT in primary mandibular reconstruction with virtually planned vascularized bone flaps.
在使用虚拟规划的带血管骨瓣进行一期下颌骨重建时,利用SPECT-CT确定炎症性颌骨病变中足够的骨切除边缘。
Clin Oral Investig. 2025 Jan 28;29(1):93. doi: 10.1007/s00784-025-06170-2.
4
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS.乳腺癌和前列腺癌患者CTIBL管理中的药物相关性骨坏死(MRONJ)。SIPMO和SIOMMMS联合报告
J Bone Oncol. 2024 Dec 16;50:100656. doi: 10.1016/j.jbo.2024.100656. eCollection 2025 Feb.
5
Fibula flap reconstruction for maxillary stage 3 medication-related osteonecrosis of the jaw from recipient and donor site perspectives: a preliminary single-center study.从受区和供区角度看腓骨瓣重建上颌骨3期药物相关性颌骨坏死:一项初步单中心研究
BMC Oral Health. 2024 Dec 26;24(1):1553. doi: 10.1186/s12903-024-05306-2.
6
Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.硬化骨:药物相关性颌骨骨坏死患者骨反应的一个征象。
Sci Rep. 2024 Apr 4;14(1):7914. doi: 10.1038/s41598-024-57635-5.
7
Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.药物相关性下颌骨坏死(MRONJ):发病机制假说和治疗策略的综述。
Arch Toxicol. 2024 Mar;98(3):689-708. doi: 10.1007/s00204-023-03653-7. Epub 2023 Dec 28.
8
Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF-SIPMO and AAOMS Guidelines.药物相关性颌骨坏死:SICMF - SIPMO与美国口腔颌面外科医师协会指南的比较
Diagnostics (Basel). 2023 Jun 21;13(13):2137. doi: 10.3390/diagnostics13132137.
9
Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations.药物相关性颌骨坏死临床试验报告规范:综述与建议。
Cells. 2022 Dec 16;11(24):4097. doi: 10.3390/cells11244097.
10
Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case Series.臭氧注射治疗颌骨坏死:病例系列
J Clin Med. 2022 Sep 9;11(18):5307. doi: 10.3390/jcm11185307.